Treatment of mice with human recombinant interleukin-2 augments resistance to the facultative intracellular pathogen Listeria monocytogenes.

The effects of exogenously administered human recombinant IL-2 (hrIL-2) on resistance to Listeria monocytogenes infection were examined. Intravenous injection of hrIL-2 significantly enhanced antibacterial resistance in both BDF1 and C3H/HeJ mice. The beneficial effect of hrIL-2 was observed with as...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Infect Immun
Päätekijät:	Haak-Frendscho, M, Young, K M, Czuprynski, C J
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1989
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC260764/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2789191/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.57.10.3014-3021.1989
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!